News | August 21, 2023
Venus Remedies launches its flagship R&D drug Elores in Oman
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Jeet will be a trusted partner in cardiovascular care
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CiplaMed 2.0 leverages advanced analytics and automation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
Subscribe To Our Newsletter & Stay Updated
